Neuroendocrine dysfunction in PCOS: a critique of recent reviews.
作者信息
Doi Suhail A R
机构信息
Division of Endocrinology, Mubarak Al-Kabeer Hospital and Kuwait University, Kuwait.
出版信息
Clin Med Res. 2008 Sep;6(2):47-53. doi: 10.3121/cmr.2008.796.
Abstract
摘要
相似文献
1
Neuroendocrine dysfunction in PCOS: a critique of recent reviews.
Clin Med Res. 2008 Sep;6(2):47-53. doi: 10.3121/cmr.2008.796.
2
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
Hum Reprod Update. 2006 Jul-Aug;12(4):351-61. doi: 10.1093/humupd/dml017. Epub 2006 May 2.
3
Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Semin Reprod Med. 2007 Sep;25(5):352-9. doi: 10.1055/s-2007-984741.
4
The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology.
Best Pract Res Clin Obstet Gynaecol. 2004 Oct;18(5):685-706. doi: 10.1016/j.bpobgyn.2004.05.004.
5
[The neuroendocrine mechanisms of the development of the anovulatory hyperandrogenic syndrome in rats].
Fiziol Zh (1994). 1995 Sep-Dec;41(5-6):33-7.
6
Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
Panminerva Med. 2008 Dec;50(4):267-78.
7
Pathological pulses in PCOS.
Mol Cell Endocrinol. 2019 Dec 1;498:110561. doi: 10.1016/j.mce.2019.110561. Epub 2019 Aug 25.
8
Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome.
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):596-601. doi: 10.1073/pnas.1415038112. Epub 2014 Dec 30.
9
Hyperandrogenaemia and the ovary.
Mol Cell Endocrinol. 2002 May 31;191(1):113-9. doi: 10.1016/s0303-7207(02)00062-x.
10
La esteroidogénesis en el síndrome de ovarios poliquísticos.
Gac Med Mex. 2019;155(2):184-190. doi: 10.24875/GMM.18003955.
引用本文的文献
1
Clinical Phenotypes of PCOS: a Cross-Sectional Study.
Reprod Sci. 2023 Nov;30(11):3261-3272. doi: 10.1007/s43032-023-01262-4. Epub 2023 May 22.
2
The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis.
Front Physiol. 2022 May 9;13:741285. doi: 10.3389/fphys.2022.741285. eCollection 2022.
3
The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review.
J Turk Ger Gynecol Assoc. 2018 Nov 15;19(4):220-232. doi: 10.4274/jtgga.2018.0077. Epub 2018 Oct 9.
4
A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).
Lipids Health Dis. 2018 Aug 21;17(1):195. doi: 10.1186/s12944-018-0839-9.
本文引用的文献
1
Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Semin Reprod Med. 2007 Sep;25(5):352-9. doi: 10.1055/s-2007-984741.
2
Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Clin Endocrinol (Oxf). 2007 Apr;66(4):513-7. doi: 10.1111/j.1365-2265.2007.02764.x.
3
Steroidogenic alterations and adrenal androgen excess in PCOS.
Steroids. 2006 Sep;71(9):751-9. doi: 10.1016/j.steroids.2006.05.005. Epub 2006 Jun 16.
4
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
Hum Reprod Update. 2006 Jul-Aug;12(4):351-61. doi: 10.1093/humupd/dml017. Epub 2006 May 2.
5
Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome.
J Endocrinol Invest. 2005 Nov;28(10):882-92. doi: 10.1007/BF03345319.
6
Irregular cycles and steroid hormones in polycystic ovary syndrome.
Hum Reprod. 2005 Sep;20(9):2402-8. doi: 10.1093/humrep/dei093. Epub 2005 Jun 2.
7
PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?
Eur J Obstet Gynecol Reprod Biol. 2005 Jan 10;118(1):4-16. doi: 10.1016/j.ejogrb.2004.06.024.
8
Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
Obstet Gynecol Surv. 2004 Feb;59(2):141-54. doi: 10.1097/01.OGX.0000109523.25076.E2.
9
Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia.
Rocz Akad Med Bialymst. 2003;48:131-4.
10
Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
Clin Endocrinol (Oxf). 2004 Feb;60(2):241-9. doi: 10.1111/j.1365-2265.2004.01973.x.
Zotero 插件